finanzen.net
11.01.2019 12:00
Bewerten
(0)

Global $175 Mn Hemostasis Valve Market to 2023 - Key Players Include Boston Scientific, Abbott, Teleflex, B. Braun Melsungen, and Freudenberg Medical

DRUCKEN

DUBLIN, Jan. 11, 2019 /PRNewswire/ --

The report has been added to ResearchAndMarkets.com's offering.

The global hemostasis valves market is projected to reach USD 175.05 million by 2023 from USD 132.05 million in 2018, at a CAGR of 5.8% during the forecast period.

A hemostasis valve is used to reduce blood loss and optimize an interventional device during the interventional procedure. The hemostasis valve is made up of a plastic valve. The valve includes a lateral port for flushing and a seal at the proximal end which closes the catheter to prevent bleeding.

The growth in this market is attributed to the increasing number of interventional procedures. Emerging markets will be the key growth hotspots in the hemostasis valves market; a favorable market scenario in these countries will serve to attract a number of players to focus on opportunities there.

In this report, the market has been segmented by type, application, end user, and region. The hemostasis valves market is segmented into four major geographic segments - North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America is expected to command the largest share of 41.3% of the global hemostasis valves market, followed by Europe. The large share of the North American market is attributed to increasing number of interventional surgeries and rising geriatric population. The Asia Pacific market, on the other hand, is projected to register the highest growth in the forecast period.

Factors such as the increasing number of hospitals, growing population, and the increasing number of interventional procedures are driving the growth of the hemostasis valves market.

The major players operating in this market are Boston Scientific (US), Abbott (US), Teleflex Incorporated (US), B. Braun Melsungen (Germany), and Freudenberg Medical (US).

Key Topics Covered:

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology
2.1 Secondary Data
2.2 Primary Data
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Hemostasis Valves: Market Overview
4.2 North America: Hemostasis Valves Market, By Application (2018)
4.3 Geographical Snapshot of the Hemostasis Valves Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Interventional Procedures
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.2.2 Growth in the Number of Hospitals

6 Hemostasis Valves Market, By Type
6.1 Introduction
6.2 Hemostasis Valve Y-Connectors
6.2.1 Hemostasis Valve Y-Connectors Segment to Account for the Largest Share of the Hemostasis Valves Market During the Forecast Period
6.3 Double Y-Connector Hemostasis Valves
6.3.1 Double Y-Connector Hemostasis Valves are the Fastest-Growing Segment of the One-Handed Hemostasis Valves Market
6.4 One-Handed Hemostasis Valves
6.4.1 Self-Closing Mechanism of One-Handed Hemostasis Valves to Drive Adoption
6.5 Other Hemostasis Valves

7 Hemostasis Valves Market, By Application
7.1 Introduction
7.2 Angiography
7.2.1 Increasing Number of Coronary Angiography Procedures to Drive Market Growth
7.3 Angioplasty
7.3.1 Increasing Burden of Coronary Heart Disease to Drive Market Growth

8 Hemostasis Valves Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Access to Advanced Facilities and Skilled Personnel is Driving Patient Preference for Hospital Care
8.3 Other End Users

9 Hemostasis Valves Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 Rising Target Disease Incidence has Aided the Adoption of New Technologies in the Us
9.2.2 Canada
9.2.2.1 Increasing Number of Pci Procedures
9.3 Europe
9.3.1 Germany
9.3.1.1 Increasing Number of Intervention Procedures
9.3.2 UK
9.3.2.1 Rising Geriatric Population
9.3.3 France
9.3.3.1 Rising Geriatric Population
9.3.4 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China Will Account for the Largest Share of the APAC Market
9.4.2 India
9.4.2.1 High Prevalence of Target Diseases Will Ensure Demand Growth in India
9.4.3 Japan
9.4.3.1 CVD Mortality has Decreased in the Country
9.4.4 Rest of Asia Pacific
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.2 Market Ranking Analysis, 2017
10.3 Competitive Scenario
10.3.1 Acquisitions
10.3.2 Expansions
10.3.3 Product Launches
10.3.4 Collaborations

11 Company Profiles

  • Abbott
  • Argon Medical
  • B. Braun Melsungen AG
  • Boston Scientific
  • Deroyal Industries, Inc.
  • Freudenberg Medical (A Subsidiary of Freudenberg Group)
  • Merit Medical Systems
  • Scitech
  • Teleflex Incorporated
  • Terumo

For more information about this report visit

Research and Markets also offers services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
 

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:

SOURCE Research and Markets

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Fünf deutsche Internet-Aktien, die Sie kennen sollten!

Das Gute liegt oft so nah. Heimische Internet-Unternehmen rollen den Markt auf. Im neuen Anlegermagazin erwartet Sie ein Special über deutsche Internet-Aktien, die Sie kennen sollten.
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX über 11.200 Punkten -- Dow fester -- HelloFresh legt 2018 stärker zu als erwartet -- Tesla streicht Stellen -- Netflix: Umsatz unter Erwartungen -- Lufthansa, MorphoSys im Fokus

Daimler ändert Methodik seiner Prognosen ab Geschäftsjahr 2019. Sinkende Profitabilität bei Drägerwerk. US-Justiz verklagt vier ehemalige Audi-Manager im Diesel-Skandal. S&T kündigt Aktienrückkauf an. BMW erhält von Brilliance-Aktionären grünes Licht für Anteilserhöhung. Versicherung macht Gewinnplanung von WACKER CHEMIE zunichte. Telecom Italia erfüllt 2018 Gewinnerwartung.

Die 5 beliebtesten Top-Rankings

Erster Job
Wo Absolventen am meisten Geld verdienen
Abschlüsse der DAX-Chefs
Diese Studiengänge haben die DAX-Chefs absolviert
Die Performance der DAX 30-Werte in 2018.
Welche Aktie macht das Rennen?
Das sind die reichsten Länder Welt 2018
USA nicht mal in den Top 10
Die Performance der Rohstoffe in in 2018.
Welcher Rohstoff macht das Rennen?
mehr Top Rankings

Umfrage

Wie viele Zinserhöhungen der US-Notenbank erwarten Sie 2019?

finanzen.net Brokerage

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Daimler AG710000
Scout24 AGA12DM8
Apple Inc.865985
BASFBASF11
Amazon906866
Allianz840400
Aurora Cannabis IncA12GS7
BMW AG519000
CommerzbankCBK100
E.ON SEENAG99
TeslaA1CX3T
Wirecard AG747206
Deutsche Telekom AG555750
BayerBAY001